Earnings Call · Q4 FY2022·2023-02-21

Q4 22EPS +5.36%·Rev n/aQ3 22EPS -3.85%·Rev n/aQ2 22EPS +5.66%·Rev n/aQ1 22EPS -10.64%·Rev n/a⚠ consensus missing

GLOBUS MEDICAL INC GMED

Brian Kearns — Investor Relations or IR Host

Dan Scavilla — President and CEO

Keith Pfeil — Chief Financial Officer

+0.5%1d on move date+0.6% vs SPY3d−0.6%5d−1.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GMED calls or request research access.

More GMED calls Browse calls Request research access